Covance appoints new head of expanded CV therapeutic area
This article was originally published in Scrip
Executive Summary
Princeton, New Jersey-based Covance has named Dr Barry J Goldstein vice-president and global therapeutic area head of its expanded cardiovascular, metabolic, endocrine and renal unit. He will join Covance's medical and scientific affairs leadership team, based in Princeton. Dr Goldstein joins Covance from Merck where, since 2008, he served as vice-president in clinical research and therapeutic area head for diabetes and endocrinology.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.